Navigation Links
Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C.
Date:6/7/2011

NEW YORK, June 7, 2011 /PRNewswire/ -- A class action alleging Forest Labs (NYSE: FRX) pharmaceutical sales representatives were unlawfully denied overtime pay has been certified by a New York federal court, The Ottinger Firm, P.C., announced today.

U.S. District Judge William H. Pauley, of the Southern District of New York, granted the plaintiffs' motion for conditional collective action certification under the federal Fair Labor Standards Act (FLSA).

The national "opt-in" class includes Forest Labs sales representatives who were employed by the company in the three years before the case was filed in August 2010. The Ottinger Firm is proposed counsel for members of the class.

The case is "Elmaria Martinez, et al., v. Forest Laboratories, Inc., et al.," Civil Action No. 10 cv 6032 (WHP) in the U.S. District Court, Southern District of New York.

The defendants are New York-based Forest Laboratories, Inc. and subsidiary Forest Pharmaceuticals, Inc. The named plaintiff, Ms. Martinez, was employed by the defendants between 2002 and 2011.

Attorney Robert W. Ottinger said, "This is a notable victory for Ms. Martinez and the Forest Labs pharmaceutical sales representatives covered by this class action. We believe the strength of this case and recent appellate court rulings confirm the overtime eligibility for these pharmaceutical sales representatives under the FLSA. We are pleased the Court conditionally certified this class action and look forward to moving forward with the case."

The Court determined that Ms. Martinez and the putative class were similarly situated in light of their common classification as exempt from overtime under the FLSA, because they shared common job descriptions and because they were subject to common employment policies, Mr. Ottinger said.

Attorney Contacts: Robert W. Ottinger and Christopher Q. Davis, The Ottinger Firm, P.C., New York, 212.571.2000, www.ottingerlaw.com.


'/>"/>
SOURCE The Ottinger Firm, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Comments on Court Ruling in Amylin Litigation
2. Federal Court Asked to Compel Decision in Marijuana Scheduling Action
3. 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
4. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
5. McDonald Hopkins Law Firm Alert: Recent Court of Appeals Decision Highlights the Need to Properly Define the Role of Sales Representatives
6. Verathon Inc. GlideScope Video Laryngoscope Patent Upheld in Court
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
10. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
11. Court Rules on First Set of Patents in FENTORA Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):